Scott Nolan

424 total citations
16 papers, 306 citations indexed

About

Scott Nolan is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Scott Nolan has authored 16 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Scott Nolan's work include Cholinesterase and Neurodegenerative Diseases (5 papers), Alzheimer's disease research and treatments (4 papers) and Computational Drug Discovery Methods (4 papers). Scott Nolan is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (5 papers), Alzheimer's disease research and treatments (4 papers) and Computational Drug Discovery Methods (4 papers). Scott Nolan collaborates with scholars based in United States, Canada and Belgium. Scott Nolan's co-authors include Anne M. Baranger, J. C. Shiels, Ashis K. Basu, Garth T. Whiteside, Gang Wu, Gary Lee, Mark Niosi, Victor I. Ilyin, Michelle Pearson and Kenneth J. Valenzano and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Scott Nolan

15 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Nolan United States 11 157 70 66 58 47 16 306
Joaquín Botta United Kingdom 12 237 1.5× 47 0.7× 32 0.5× 90 1.6× 11 0.2× 15 402
Mark J. Gemkow Germany 11 231 1.5× 50 0.7× 46 0.7× 115 2.0× 19 0.4× 15 389
Kenichi Kishii Japan 15 206 1.3× 43 0.6× 93 1.4× 171 2.9× 7 0.1× 25 424
Ginny D. Ho United States 13 301 1.9× 68 1.0× 127 1.9× 193 3.3× 22 0.5× 22 458
Toyokazu Hiranuma Japan 13 274 1.7× 98 1.4× 110 1.7× 248 4.3× 15 0.3× 26 504
Gregory A. Gfesser United States 11 220 1.4× 28 0.4× 211 3.2× 40 0.7× 21 0.4× 18 439
Heather Coate United States 9 172 1.1× 50 0.7× 80 1.2× 99 1.7× 6 0.1× 13 331
Marjolein Soethoudt Netherlands 12 302 1.9× 34 0.5× 105 1.6× 120 2.1× 40 0.9× 15 573
Sandra L. Cockerham United States 10 188 1.2× 83 1.2× 68 1.0× 210 3.6× 5 0.1× 25 521
Amanda J. Wheal United Kingdom 10 229 1.5× 31 0.4× 21 0.3× 108 1.9× 24 0.5× 10 429

Countries citing papers authored by Scott Nolan

Since Specialization
Citations

This map shows the geographic impact of Scott Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Nolan more than expected).

Fields of papers citing papers by Scott Nolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Nolan. The network helps show where Scott Nolan may publish in the future.

Co-authorship network of co-authors of Scott Nolan

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Nolan. A scholar is included among the top collaborators of Scott Nolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Nolan. Scott Nolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bursavich, Matthew G., Bryce A. Harrison, Lori Hrdlicka, et al.. (2021). Discovery of the Oxadiazine FRM-024: A Potent CNS-Penetrant Gamma Secretase Modulator. Journal of Medicinal Chemistry. 64(19). 14426–14447. 8 indexed citations
2.
Bursavich, Matthew G., Bryce A. Harrison, Lori Hrdlicka, et al.. (2017). Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease. Journal of Medicinal Chemistry. 60(6). 2383–2400. 24 indexed citations
3.
Blain, Jean‐François, Matthew G. Bursavich, Lori Hrdlicka, et al.. (2016). Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease. Alzheimer s Research & Therapy. 8(1). 34–34. 16 indexed citations
4.
Nolan, Scott, et al.. (2016). Diabetes Self-Management Education (DSME) program for glycemic control. 2(3). 6 indexed citations
5.
Tang, Cuyue, Ting Chen, Tao Yi, et al.. (2014). Neuropharmacokinetics of two investigational compounds in rats: Divergent temporal profiles in the brain and cerebrospinal fluid. Biochemical Pharmacology. 91(4). 543–551. 11 indexed citations
6.
Felsenstein, Kevin M., Zhiyong Yang, Scott Nolan, et al.. (2010). P3‐295: Pharmacokinetic and pharmacodynamic analysis of the gamma‐secretase modulator (GSM) EVP‐0015962. Alzheimer s & Dementia. 6(4S_Part_17). 4 indexed citations
7.
Leventhal, Liza, Sarah C. Hopp, Zhiyong Yang, et al.. (2010). P4‐022: The Gamma Secretase Modulator EVP‐0015962 Improves Cognitive Deficits in Tg2576 Mice Concomitant With Decreases In Aβ42. Alzheimer s & Dementia. 6(4S_Part_20). 4 indexed citations
8.
Chesworth, Richard, Kevin M. Felsenstein, Gideon Shapiro, et al.. (2009). P3‐291: Putative gamma secretase modulators lower Aβ42 in multiple in vitro and in vivo models. Alzheimer s & Dementia. 5(4S_Part_14). 1 indexed citations
9.
Huang, Jincheng, et al.. (2004). 4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 719–723. 42 indexed citations
10.
Wu, Gang, Garth T. Whiteside, Gary Lee, et al.. (2004). A-317491, a selective P2X3/P2X2/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats. European Journal of Pharmacology. 504(1-2). 45–53. 64 indexed citations
12.
Luchansky, Sarah J., Scott Nolan, & Anne M. Baranger. (2000). Contribution of RNA Conformation to the Stability of a High-Affinity RNA−Protein Complex. Journal of the American Chemical Society. 122(29). 7130–7131. 13 indexed citations
13.
Nolan, Scott, et al.. (1999). C8-Guanine Adduct-Induced Stabilization of a −1 Frame Shift Intermediate in a Nonrepetitive DNA Sequence. Biochemistry. 38(42). 14056–14062. 13 indexed citations
14.
Nolan, Scott, et al.. (1999). Recognition of an Essential Adenine at a Protein−RNA Interface:  Comparison of the Contributions of Hydrogen Bonds and a Stacking Interaction. Journal of the American Chemical Society. 121(38). 8951–8952. 57 indexed citations
15.
Nolan, Scott, et al.. (1996). Solution properties and computational analysis of an oligodeoxynucleotide containing N-(deoxyguanosin-8-yl)-1-aminopyrene. Carcinogenesis. 17(1). 133–144. 14 indexed citations
16.
Nolan, Scott, et al.. (1993). Synthesis and characterization of oligodeoxynucleotides containing N-(deoxyguanosin-8-yl)-1-aminopyrene. Tetrahedron Letters. 34(14). 2247–2250. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026